Sun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights to Sun Pharma to distribute Finerenone under the brand name Lyvelsa. Sun Pharma CEO emphasizes commitment to providing innovative medicines to Indian patients.
India Business News: Sun Pharma and Bayer have entered into an agreement to market and distribute a second brand of the patented medicine Finerenone in India. Finerenone i